SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 192.84-1.7%Jan 16 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: buyhiman who wrote (14226)2/4/1998 2:55:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
As of Monday, the NDA filing for this quarter was "on track". In fact that is the #1 priority and is delaying release of some of the Phase II clinicals, which will likely come next quarter instead of this quarter. I didn't ask about the European filing, but would assume that a US NDA filing will allow for a European filing very soon also.

The clinicals slated for release after the NDA filings are supposed to be robust enough to make believers of anyone who thinks that LGND should be trading at these grossly depressed levels.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext